How One Agency Increased Rx Volume by 70% With PulsePoint
Underscore is a global healthcare marketing company that offers media solutions for top health and wellness, healthcare, and pharma brands. The company focuses on making advertising media simple for marketers and maximizing Return on Marketing Investment (ROMI) by combining the latest in ad technology with human-led insight.
The Goal: Reach, Educate, and Promote Treatment for Rare Disease Patients
To support their pharmaceutical client, Underscore was interested in executing a campaign to reach, educate, and promote a health-advancing treatment option for rare disease patients.
Specifically, the goals of the campaign were to build and increase brand awareness for their client, hyper-target rare disease audience segments, and optimize campaign performance to increase prescription volume.
The Solution: A Programmatic Multichannel Marketing Campaign
Underscore partnered with PulsePoint to launch and optimize a hyper-targeted, multichannel campaign via programmatic marketing for a pharma client.
To effectively reach their rare disease patient demographic, PulsePoint used contextual targeting and their Life platform—the company’s programmatic technology solution—to deploy across channels including search, display, native, and video.
The campaign was continuously monitored and measured in real-time to optimize performance and make adjustments, as needed.
The Impact: A Strengthened Partnership Through Meaningful Results
The campaign yielded significant results including an 120% increase in qualified leads to their client’s website and an 70% increase in patient prescription volume.
“PulsePoint has helped drive Underscore’s programmatic growth effectively and efficiently for our clients,” said Glenniss Richards, Director of Programmatic at Underscore. “Because of PulsePoint’s targeting, data capabilities, and innovative tactics we were able to deliver results for less.”
